Lim HY - Search Results

1

Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.

Wang K, Lim HY, Shi S, Lee J, Deng S, Xie T, Zhu Z, Wang Y, Pocalyko D, Yang WJ, Rejto PA, Mao M, Park CK, Xu J. Wang K, et al. Among authors: lim hy. Hepatology. 2013 Aug;58(2):706-17. doi: 10.1002/hep.26402. Epub 2013 Jul 1. Hepatology. 2013. PMID: 23505090

2

Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma.

Lee SJ, Lee J, Park SH, Park JO, Park YS, Kang WK, Lee J, Yim DS, Lim HY. Lee SJ, et al. Among authors: lim hy. Invest New Drugs. 2012 Aug;30(4):1540-7. doi: 10.1007/s10637-011-9706-5. Epub 2011 Jun 22. Invest New Drugs. 2012. PMID: 21695438 Clinical Trial.

3

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.

Baek KK, Kim JH, Uhm JE, Park SH, Lee J, Park JO, Park YS, Kang WK, Lim HY. Baek KK, et al. Among authors: lim hy. Oncology. 2011;80(3-4):167-74. doi: 10.1159/000327591. Epub 2011 Jun 24. Oncology. 2011. PMID: 21701230

4

Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma.

Ahn HK, Lee S, Sun JM, Lee J, Park SH, Park JO, Park YS, Kang WK, Lim HY. Ahn HK, et al. Among authors: lim hy. Invest New Drugs. 2012 Aug;30(4):1768-72. doi: 10.1007/s10637-011-9707-4. Epub 2011 Jul 1. Invest New Drugs. 2012. PMID: 21720741 No abstract available.

5

PIK3CA mutations in hepatocellular carcinoma in Korea.

Kim H, Park CK, Lee SJ, Rha SY, Park KH, Lim HY. Kim H, et al. Among authors: lim hy. Yonsei Med J. 2013 Jul;54(4):883-7. doi: 10.3349/ymj.2013.54.4.883. Yonsei Med J. 2013. PMID: 23709421 Free PMC article.

6

Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.

Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK. Lim HY, et al. Ann Surg Oncol. 2013 Nov;20(12):3747-53. doi: 10.1245/s10434-013-3070-y. Epub 2013 Jun 26. Ann Surg Oncol. 2013. PMID: 23800896

7

A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.

Lee SJ, Lee J, Sohn I, Mao M, Kai W, Park CK, Lim HY. Lee SJ, et al. Among authors: lim hy. Anticancer Res. 2013 Nov;33(11):5179-86. Anticancer Res. 2013. PMID: 24222167

8

Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas.

Ouyang L, Lee J, Park CK, Mao M, Shi Y, Gong Z, Zheng H, Li Y, Zhao Y, Wang G, Fu H, Kim J, Lim HY. Ouyang L, et al. Among authors: lim hy. BMC Med Genomics. 2014 Jan 9;7:2. doi: 10.1186/1755-8794-7-2. BMC Med Genomics. 2014. PMID: 24405831 Free PMC article.

9

Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer.

Yi JH, Do IG, Jang J, Kim ST, Kim KM, Park SH, Park JO, Park YS, Lim HY, Kang WK, Lee J. Yi JH, et al. Among authors: lim hy. Sci Rep. 2014 Dec 23;4:7592. doi: 10.1038/srep07592. Sci Rep. 2014. PMID: 25534230 Free PMC article. Clinical Trial.

10

Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.

Lee J, Kim HC, Hong JY, Wang K, Kim SY, Jang J, Kim ST, Park JO, Lim HY, Kang WK, Park YS, Lee J, Lee WY, Park YA, Huh JW, Yun SH, Do IG, Kim SH, Balasubramanian S, Stephens PJ, Ross JS, Li GG, Hornby Z, Ali SM, Miller VA, Kim KM, Ou SH. Lee J, et al. Among authors: lim hy. Oncotarget. 2015 Sep 15;6(27):24320-32. doi: 10.18632/oncotarget.4462. Oncotarget. 2015. PMID: 26172300 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

679 results

Search Page

Filters